- KR₩175bn
- KR₩229bn
- KR₩136bn
- 28
- 34
- 52
- 29
Annual income statement for Macrogen, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 112,603 | 129,175 | 138,617 | 132,803 | 135,777 |
Cost of Revenue | |||||
Gross Profit | 42,190 | 52,158 | 53,593 | 49,240 | 47,129 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 101,506 | 126,758 | 141,440 | 144,482 | 147,908 |
Operating Profit | 11,098 | 2,417 | -2,822 | -11,678 | -12,131 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5,550 | 14,904 | -29,104 | -20,233 | -9,897 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3,805 | 2,312 | -22,005 | -16,751 | -7,784 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 88,337 | 1,112 | -22,253 | -16,814 | -7,603 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 88,475 | 1,112 | -22,253 | -16,814 | -7,603 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 97.3 | 736 | -1,705 | -861 | -370 |
Dividends per Share |